Skip to main content
SpringerLink
Log in

Herz oder Hirn?

Problempatienten an der Schnittstelle zwischen Kardiologie und Neurologie

Heart or brain?

Problem patients at the interface between cardiology and neurology

  • CME Zertifizierte Fortbildung
  • Published:
Herz Aims and scope Submit manuscript

Zusammenfassung

Viele Patienten bewegen sich an der Schnittstelle „Herz oder Hirn“, an der häufig fundiertes Wissen sowohl aus kardiologischer als auch aus neurologischer Sicht für eine patientengerechte Therapie notwendig ist. Der vorliegende Artikel soll anhand relevanter Krankheitsbilder wichtige klinische Entscheidungshilfen bei diesen „Schnittpunktpatienten“ erläutern. Exemplarisch herausgegriffen werden dabei Patienten, bei denen eine Karotisstenose, ein offenes Foramen ovale oder nichtvalvuläres Vorhofflimmern besteht.

Abstract

A large number of patients fall into a category at the interface between heart or brain and are expected to require thorough clinical knowledge from both the cardiological as well as the neurological point of view for further patient-oriented treatment. The current article therefore addresses this important issue and aims to provide important information for clinical decision making for those patients at the interface between heart and brain. Due to the clinical impact, patients with carotid stenosis, a patent foramen ovale or non-valvular atrial fibrillation are described in more detail in this article.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Arning C, Widder B, Reutern GM von et al (2010) Revision of DEGUM ultrasound criteria for grading internal carotid artery stenoses and transfer to NASCET measurement. Ultraschall Med 31:251–257

    Article  PubMed  CAS  Google Scholar 

  2. (o A) (1995) Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 273:1421–1428

    Google Scholar 

  3. (o A) (1998) Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 351:1379–1387

    Google Scholar 

  4. Fairhead JF, Mehta Z, Rothwell PM (2005) Population-based study of delays in carotid imaging and surgery and the risk of recurrent stroke. Neurology 65:371–375

    Article  PubMed  CAS  Google Scholar 

  5. Bangalore S, Kumar S, Wetterslev J et al (2011) Carotid artery stenting vs carotid endarterectomy: meta-analysis and diversity-adjusted trial sequential analysis of randomized trials. Arch Neurol 68:172–184

    Article  PubMed  Google Scholar 

  6. Bonati LH, Dobson J, Algra A et al (2010) Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient data. Lancet 376:1062–1073

    Article  PubMed  Google Scholar 

  7. Rothwell PM, Eliasziw M, Gutnikov SA et al (2004) Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 363:915–924

    Article  PubMed  CAS  Google Scholar 

  8. Rothwell PM (2004) ACST: which subgroups will benefit most from carotid endarterectomy? Lancet 364:1122–1123

    Article  PubMed  Google Scholar 

  9. Gray WA, Chaturvedi S, Verta P (2009) Thirty-day outcomes for carotid artery stenting in 6320 patients from 2 prospective, multicenter, high-surgical-risk registries. Circ Cardiovasc Interv 2:159–166

    Article  PubMed  Google Scholar 

  10. Abbott AL (2009) Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke 40:E573–E583

    Article  PubMed  Google Scholar 

  11. Marquardt L, Geraghty OC, Mehta Z et al (2010) Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study. Stroke 41:E11–E17

    Article  PubMed  Google Scholar 

  12. Laufs U, Hoppe UC, Rosenkranz S et al (2010) Cardiological evaluation after cerebral ischaemia: consensus statement of the Working Group Heart and Brain of the German Cardiac Society-Cardiovascular Research (DGK) and the German Stroke Society (DSG). Clin Res Cardiol 99:609–625

    Article  PubMed  Google Scholar 

  13. Hagen PT, Scholz DG, Edwards WD (1984) Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 59:17–20

    Article  PubMed  CAS  Google Scholar 

  14. Lechat P, Mas JL, Lascault G et al (1988) Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 318:1148–1152

    Article  PubMed  CAS  Google Scholar 

  15. Mas JL, Arquizan C, Lamy C et al (2001) Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 345:1740–1746

    Article  PubMed  CAS  Google Scholar 

  16. Almekhlafi MA, Wilton SB, Rabi DM et al (2009) Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis. Neurology 73:89–97

    Article  PubMed  CAS  Google Scholar 

  17. Wahl A, Juni P, Mono ML et al (2012) Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism. Circulation 125:803–812

    Article  PubMed  Google Scholar 

  18. Kitsios GD, Dahabreh IJ, Abu Dabrh AM et al (2012) Patent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidence. Stroke 43:422–431

    Article  PubMed  Google Scholar 

  19. Furlan AJ, Reisman M, Massaro J et al (2012) Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 366:991–999

    Article  PubMed  CAS  Google Scholar 

  20. Johnston SC (2012) Patent foramen ovale closure – closing the door except for trials. N Engl J Med 366:1048–1050

    Article  PubMed  CAS  Google Scholar 

  21. Hart RG, Pearce LA, Aguilar MI (2007) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146:857–867

    Article  PubMed  Google Scholar 

  22. Glader EL, Sjolander M, Eriksson M et al (2010) Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke. Stroke 41:397–401

    Article  PubMed  Google Scholar 

  23. Haeusler KG, Konieczny M, Endres M et al (2012) Impact of anticoagulation before stroke on stroke severity and long-term survival. Int J Stroke 7:544–550

    Article  PubMed  Google Scholar 

  24. Mant J, Hobbs FD, Fletcher K et al (2007) Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 370:493–503

    Article  PubMed  CAS  Google Scholar 

  25. Baker WL, Phung OJ (2012) Systematic review and adjusted indirect comparison meta-analysis of oral anticoagulants in atrial fibrillation. Circ Cardiovasc Qual Outcomes 5:711–719

    Article  PubMed  Google Scholar 

  26. Stahrenberg R, Weber-Kruger M, Seegers J et al (2010) Enhanced detection of paroxysmal atrial fibrillation by early and prolonged continuous holter monitoring in patients with cerebral ischemia presenting in sinus rhythm. Stroke 41:2884–2888

    Article  PubMed  Google Scholar 

  27. Healey JS, Connolly SJ, Gold MR et al (2012) Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 366:120–129

    Article  PubMed  CAS  Google Scholar 

  28. Wachter R, Stahrenberg R, Groschel K (2013) Subclinical atrial fibrillation: how hard should we look? Heart 99:151–153

    Article  PubMed  Google Scholar 

  29. Camm AJ, Lip GY, De Caterina R et al (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33:2719–2747

    Article  PubMed  Google Scholar 

  30. Pisters R, Lane DA, Nieuwlaat R et al (2010) A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138:1093–1100

    Article  PubMed  Google Scholar 

  31. Ntaios G, Papavasileiou V, Diener HC et al (2012) Nonvitamin-K-antagonist oral anticoagulants in patients with atrial fibrillation and previous stroke or transient ischemic attack: a systematic review and meta-analysis of randomized controlled trials. Stroke 43:3298–3304

    Article  PubMed  CAS  Google Scholar 

  32. Man-Son-Hing M, Nichol G, Lau A et al (1999) Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Arch Intern Med 159:677–685

    Article  PubMed  CAS  Google Scholar 

  33. Carroll JD, Saver JL, Thaler DE et al (2013) Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 368:1092–1100

    Article  PubMed  CAS  Google Scholar 

  34. Meier B, Kalesan B, Mattle HP et al (2013) Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med 368:1083–1091

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt für sich und seine Koautoren an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Neurologie, Universitätsmedizin Mainz, Langenbeckstr. 1, 55131, Mainz, Deutschland

    K. Gröschel

  2. Neurologische Abteilung, Asklepios Klinik Altona, Hamburg, Deutschland

    J. Röther

  3. Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Homburg/Saar, Deutschland

    U. Laufs

  4. Klinik für Kardiologie und Pneumologie, Universitätsmedizin Göttingen, Göttingen, Deutschland

    R. Wachter

  5. Deutsches Zentrum für Herz-/Kreislaufforschung (DZHK), Berlin, Deutschland

    R. Wachter

Authors
  1. K. Gröschel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Röther
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. U. Laufs
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Wachter
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

Für die Arbeitsgemeinschaft Herz & Hirn der Deutschen Schlaganfall-Gesellschaft und der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e. V.

Corresponding author

Correspondence to K. Gröschel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gröschel, K., Röther, J., Laufs, U. et al. Herz oder Hirn?. Herz 38, 395–404 (2013). https://doi.org/10.1007/s00059-013-3807-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00059-013-3807-1

Schlüsselwörter

Keywords

Search

Navigation